COVID-19 UPDATE: Under the 14-day quarantine travel advisory announced by the Governors of New Jersey, New York and Connecticut, individuals traveling to or returning from states with increasing rates of COVID-19 are advised to self-quarantine for 14 days. The current list of states, which will be updated regularly, can be found at NY.Gov and NJ.Gov. This includes travel by train, bus, car, plane and any other method of transportation. If you have traveled to one of these states and have stayed longer than 24 hours, we kindly request you self-quarantine at home for 14 days prior to coming into the office. If you would like to schedule a Virtual Appointment, please call 1-855-ENTA-DOC. For more information on how ENTA is taking extra precautions to provide the safest environment possible during the COVID-19 pandemic, please click here.
Meniere’s disease/Endolymphatic hydrops
Meniere’s disease involves the combination of ear pressure, tinnitus, hearing loss, and vertigo, and is the result of excess pressure of endolymphatic fluid in the inner ear. However, atypical forms of Meniere’s disease may result in virtually any combination of the above symptoms. The disease typically persists for several months, and may then go into remission. The condition may then re-emerge after periods of stress, dehydration, or high salt intake. Both the hearing and balance function may diminish with such recurrences.
Meniere’s disease usually occurs in only one ear, but may involve both ears in 10% of patients.
The first stage of treatment for Meniere’s disease involves diuretics, salt restriction, oral steroids, aggressive oral hydration, allergy treatment, and avoidance of caffeine, alcohol, and stress.
The second stage of treatment involves injections of steroids or gentamicin into the ear, the minimally invasive Meniett device, or endolymphatic sac-mastoid shunt surgery.
The third stage of treatment involves such measures as a labyrinthectomy or vestibular nerve section. Fortunately, the third stage of treatment is rarely necessary.
Of note, there is considerable overlap in symptoms between migraine-associated dizziness and Meniere’s disease, and the former should be considered in patients for whom treatments for presumed Meniere’s disease prove ineffective.